We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 13

Executive pay packages: compensation planning in light of increased scrutiny
  • Gowling WLG
  • Canada, Global
  • November 11 2010

Executive compensation practices that encourage excessive risk taking have been identified by governments and the public as a contributing factor in the recent economic crisis that threatened the global financial system.


Corporate social responsibility: what every OHS professional needs to know
  • Gowling WLG
  • Canada, Global
  • October 20 2010

Over the past decade, there has been increasing interest in the concept of Corporate Social Responsibility ("CSR"), and the proposition that corporations should take into account the interests of stakeholders other than their shareholders.


European generics pressing for global agreement on biosimilars
  • Gowling WLG
  • Global
  • September 21 2010

The European Generic Medicines Association (EGA) is pressing governments to draft a global agreement regarding the approval process for biosimilar medicines ("follow-on biologics").


Globally Harmonized System (GHS)
  • Gowling WLG
  • Global
  • January 15 2009

Globally Harmonized System, or “GHS” is a new international system of Classification and Labelling of Chemicals.


Proposed compulsory licensing regime to encourage innovation
  • Gowling WLG
  • Global
  • August 15 2007

Governments are currently permitted to issue patent compulsory licenses under World Trade Organization Rules, which allow countries to manufacture cheaper versions of patented drugs for non-commercial use or in cases of health care emergencies.




Douglas Clarke
  • Gowling WLG

Mark Kirkey
  • Gowling WLG

Gordon Harris
  • Gowling WLG